Altered expression of caspases‐4 and ‐5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2249|181|1|39-50

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.1, 2015-07, pp. : 39-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phytochemicals and Their Potential Usefulness in Inflammatory Bowel Disease

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 3, 2015-03 ,pp. : 339-350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease

By Pasternak Björn   Svanström Henrik   Schmiegelow Kjeld   Jess Tine   Hviid Anders  

American Journal of Epidemiology, Vol. 177, Iss. 11, 2013-06 ,pp. : 1296-1305

Oxford University Press

Access to resources Recommend Favorite

Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?

By Kruidenier L.   Verspaget H. W.  

Mediators of Inflammation, Vol. 7, Iss. 3, 1998-06 ,pp. : 157-162

Informa Healthcare

Access to resources Recommend Favorite

Circulating miR‐221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 10, 2010-10 ,pp. : 1674-1680

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 5, 2015-03 ,pp. : 494-495

John Wiley & Sons Inc

Access to resources Recommend Favorite